Comment on Johnson et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care 2019;42:69-76

Jane Frances Grace Lustre Estrella^{1

2}, David Simmons^{3

4}

Affiliations

¹ School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia.
² Campbelltown Hospital, Campbelltown, New South Wales, Australia.
³ School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia da.simmons@westernsydney.edu.au.
⁴ Campbelltown Hospital, Campbelltown, New South Wales, Australia da.simmons@westernsydney.edu.au.

Comment

Jane Frances Grace Lustre Estrella et al. Diabetes Care. 2019 May.

. 2019 May;42(5):e78.

doi: 10.2337/dc19-0043.

Jane Frances Grace Lustre Estrella^{1

2}, David Simmons^{3

4}

¹ School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia.
² Campbelltown Hospital, Campbelltown, New South Wales, Australia.
³ School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia da.simmons@westernsydney.edu.au.
⁴ Campbelltown Hospital, Campbelltown, New South Wales, Australia da.simmons@westernsydney.edu.au.

No abstract available

Comment in

Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life.
Johnson SR, Carter HE, Leo P, Hollingworth SA, Davis EA, Jones TW, Conwell LS, Harris M, Brown MA, Graves N, Duncan EL. Johnson SR, et al. Diabetes Care. 2019 Jan;42(1):69-76. doi: 10.2337/dc18-0261. Epub 2018 Dec 6. Diabetes Care. 2019. PMID: 30523035